PRL2 has been shown to negatively regulate PTEN protein concentration, and constitutive PRL2 KO in a PTEN-deficient animal model demonstrated enhanced tumor-free survival coincident with elevated PTEN protein levels compared with PRL2 WT animals (7). The gene discussed is PTEN; the disease is neoplasm.